US pharmacy pricing
Alunbrig Prices at US Pharmacies
Lowest price found · US pharmacies
$21,168.86/fill
for Alunbrig, across the pharmacies in our data
US pharmacy prices — 180mg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $21,168.86Lowest | $21,171.86 | $3,118.95 |
 Harris Teeter Pharmacy | $21,168.86Lowest | $21,171.86 | $3,118.95 |
 Walgreens | $22,219.22 | $22,222.22 | $3,118.95 |
 Food Lion | $22,290.92 | $22,290.92 | $3,118.95 |
 Publix | $22,351.54 | $22,354.54 | $3,118.95 |
 Walmart Neighborhood Market | $22,742.28 | $22,745.28 | $3,118.95 |
 Walmart Pharmacy | $22,742.28 | $22,745.28 | $3,118.95 |
 Costco | $22,872.85 | $22,875.85 | $3,118.95 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Alunbrig.
Frequently asked questions
How much does Alunbrig (Alunbrig) cost without insurance?
Our most recent US pharmacy data shows a low of roughly $21,168.86 for Alunbrig with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Alunbrig have a generic equivalent?
Generic and brand-name pricing for Alunbrig is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
Is there a generic of Alunbrig?
Alunbrig (brigatinib) is a brand-name medication produced by Takeda Pharmaceutical Company Limited. A generic version is not currently available in the United States. Other medications used in the treatment of various cancers include Tagrisso, Revlimid, Avastin, Tarceva, Ibrance, Imbruvica, Tasigna, Keytruda, and Jakafi, but these are not therapeutically equivalent to Alunbrig.
What is Alunbrig?
Alunbrig (brigatinib) is a prescription medication approved to treat metastatic non-small cell lung cancer (NSCLC) that tests positive for a specific genetic marker known as anaplastic lymphoma kinase (ALK). It is typically used after other ALK inhibitor treatments have failed. Patients must undergo genetic testing to confirm the presence of the ALK mutation before starting therapy. Alunbrig works by inhibiting proteins that promote cancer cell growth. It is taken orally as a tablet, usually once daily with or without food. Dosing is highly individualized; your doctor may initiate treatment at a lower dose for a week before increasing it based on your tolerance and response. It's important to take Alunbrig exactly as prescribed, at the same time each day, and not to stop or adjust the dose without medical guidance, even if you feel unwell.
What are the side effects of Alunbrig?
Common side effects of Alunbrig include nausea, diarrhea, vomiting, decreased appetite, constipation, fatigue, abdominal pain, fever, dizziness, headache, insomnia, and joint pain. Report any persistent or bothersome symptoms to your doctor. Alunbrig can also cause high blood pressure (hypertension). Patients should monitor their blood pressure regularly during treatment and inform their healthcare provider if readings become elevated, as additional medication may be required to manage it. This is not an exhaustive list of potential adverse reactions. Always discuss possible side effects with your doctor or pharmacist.